January 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.02 billion in 2025 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
December 2025
The lung disease therapeutics market size was estimated at USD 96.82 billion in 2025 and is expected to hit over USD 173.48 billion by 2035 with a CAGR of 6.01%.
November 2025
The infectious disease therapeutics market size is calculated at USD 36.22 billion in 2025 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
June 2025
The global plasma protein therapeutics market size is projcetd to cross around USD 48.43 billion by 2034 from USD 29.56 billion in 2024 with a CAGR of 5.06%.
July 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
July 2026
The global mental health digital therapeutics (DTx) market size is growing as digital tools revolutionize mental health treatment through evidence-based software.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The US peptide therapeutics market size was evaluated at USD 21.24 billion in 2025 and is predicted to hit around USD 34.98 billion by 2035, growing at a CAGR of 5.12%.
June 2026
The global brain health supplements and therapeutics market size accounted for USD 18.60 billion in 2025 and is predicted to hit around USD 47.37 billion by 2035, growing at a CAGR of 9.80%.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The global alzheimer therapeutics market size is evaluated at USD 6.49 billion in 2025 and is predicted to hit around USD 38.61 billion by 2035, growing at a CAGR of 19.52%.
June 2026
The global rheumatology therapeutics market size is evaluated at USD 51.82 billion in 2025 and is predicted to hit around USD 68.49 billion by 2035, growing at a CAGR of 2.83%.
June 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
June 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
June 2026
The global psychedelic therapeutics market size is estimated to hit around USD 12.40 billion by 2035 increasing from USD 2.94 billion in 2025, with a CAGR of 15.48%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.
June 2026
The global amyloidosis therapeutics market size was valued at USD 3.18 billion in 2025 and is expected to hit around 6.92 billion by 2035, growing at a CAGR of 8.09% from 2026 to 2035.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com